SHORT-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH INSULIN IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES IN SWEDEN

被引：1
|
作者：
Ridderstrale, M. [1 ,2 ]
Ericsson, A. [3 ]
Jensen, M. M. [4 ]
机构：
[1] Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden
[2] Univ Lund Hosp, Dept Clin Sci, Malmo, Sweden
[3] Novo Nordisk Scandinavia AB, Malmo, Sweden
[4] Novo Nordisk Scandinavia AB, Copenhagen, Denmark
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1351
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A480 / A480
页数：1
相关论文
共 50 条
  • [41] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
    Robertson, K. J.
    Schoenle, E.
    Gucev, Z.
    Mordhorst, L.
    Gall, M. -A.
    Ludvigsson, J.
    [J]. DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
  • [42] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Simon, A. C. R.
    Swinnen, S. G.
    Holleman, F.
    Hoekstra, J. B. L.
    DeVries, J. H.
    [J]. DIABETOLOGIA, 2011, 54 : S420 - S421
  • [43] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Swinnen, Sanne G.
    Simon, Airin C. R.
    Holleman, Frits
    Hoekstra, Joost B.
    DeVries, J. Hans
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [44] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in subjects with type 1 diabetes
    Heise, T
    Nosek, L
    Draeger, E
    Stender, A
    Ronn, BB
    Kapitza, C
    Heinemann, L
    [J]. DIABETES, 2003, 52 : A121 - A121
  • [45] A randomized controlled trial of insulin detemir versus insulin NPH for the treatment of pregnant women with gestational diabetes and type 2 diabetes
    Herrera, Kimberly
    Rosenn, Barak
    Foroutan, Janelle
    Bimson, Brianne
    Al Ibraheemi, Zainab
    Brustman, Lois
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 212 (01) : S320 - S320
  • [46] COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Liu, C.
    Tao, L. B.
    Wang, F.
    [J]. VALUE IN HEALTH, 2020, 23 : S111 - S111
  • [47] Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes
    Luo, Qiong
    Zhou, Li
    Zhou, Naitong
    Hu, Ming
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [48] COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Xu, J.
    Lan, K.
    Wang, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S111 - S111
  • [49] Weight change upon initiation of insulin detemir treatment with or without dietary intervention in insulin-naive patients with Type 2 diabetes
    Hollander, P.
    Piletic, M.
    Silver, H. J.
    Andersen, H.
    Hiort, L. C.
    Niswender, K.
    [J]. DIABETIC MEDICINE, 2013, 30 : E6 - E6
  • [50] Cost-Effectiveness of Insulin Detemir and Insulin Aspart in People with Type 1 Diabetes Prone to Recurrent Severe Hypoglycaemia
    Pedersen-Bjergaard, Ulrik
    Kristensen, Peter Lommer
    Norgaard, Kirsten
    Perrild, Hans
    Jensen, Tonny
    Thorsteinsson, Birger
    Nikolajsen, Annie
    Tarnow, Lise
    [J]. DIABETES, 2015, 64 : A348 - A348
12345